col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


27 Results       Page 1

 [1] 
Elsevier: Journal of Translational Autoimmunity
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2025―Apr―25 The changes in global burden of autoimmune diseases two years after the COVID-19 pandemic: a trend analysis based on the Global Burden of Disease Study 2021 Danting Zhang, Wanyu Hua, Fangfang Sun, Chao Wen, Lai Yee Cheong, Ruiyan Xie, Koon Ho Chan, Shirley C.W. Chan, Xue Li, Shuang Ye, Desmond Y.H. Yap
2 [GO] 2025―Mar―06 Pediatric Autoimmune Diseases in the Light of COVID-19 Pandemic, A Retrospective Observational Big Data Study. Rim Kasem Ali Sliman, Hilla Cohen, Shereen Shehadeh, Reut Batcir, Yigal Elenberg Alter, Keren Cohen, Ilana Koren, Inbal Halabi, Hussein Sliman, Mohamad Hamad Saied
3 [GO] 2025―Feb―21 NETosis: A key player in autoimmunity, COVID-19, and long COVID Diana M. Monsalve, Yeny Acosta-Ampudia, Nicolás Guerrero Acosta, Mariana Celis-Andrade, Ali Şahin, Ahsen Morva Yilmaz, Yehuda Shoenfeld, Carolina Ramírez-Santana
4 [GO] 2024―Oct―25 Association of COVID-19 with Thyroid Dysfunction and Autoimmune Thyroid Disease: A Retrospective Cohort Study Jia Di, Xiaodong Ma, Tao Wu, Eryue Qiao, Mojtaba Salouti, Yu Zhong, Qian Xia, Danfeng Kong, Min Hao, Qingwei Xie, Zhuang Ge, Dongzheng Liu, Juanyi Feng, Xianghong Zheng
5 [GO] 2023―Dec―12 Effect of traditional therapeutics on prevalence and clinical outcomes of coronavirus disease 2019 in Chinese patients with autoimmune diseases Saisai Huang, Xiaolei Ma, Juan Cao, Mengru Du, Zhiling Zhao, Dandan Wang, Xue Xu, Jun Liang, Lingyun Sun
6 [GO] 2023―Nov―29 Impact of the COVID-19 pandemic on temporal trends of biological indicators of autoimmunity Elliott Van Regemorter, Giulia Zorzi, Anais Scohy, Damien Gruson, Johann Morelle
7 [GO] 2023―Nov―28 Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study Chiara Tani, Chiara Cardelli, Roberto Depascale, Anna Gamba, Luca Iaccarino, Andrea Doria, Matilde Bandeira, Sara Paiva Dinis, Vasco C. Romão, Emanuele Gotelli, Sabrina Paolino, Maurizio Cutolo, Niccolò Di Giosaffatte, Alessandro Ferraris, Paola Grammatico, Lorenzo Cavagna, Veronica Codullo, Carlomaurizio Montecucco, Valentina Longo, Lorenzo Beretta, Ilaria Cavazzana, Micaela Fredi, Silvia Peretti, Serena Guiducci, Marco Matucci-Cerinic, Stefano Bombardieri, Gerd R. Burmester, João E. Fonseca, Charissa Frank, Ilaria Galetti, Eric Hachulla, Ulf Müller-Ladner, Matthias Schneider, Vanessa Smith, Farah Tamirou, Jacob M. Van Laar, Ana Vieira, Rossella D'Urzo, Sara Cannizzo, Andrea Gaglioti, Diana Marinello, Rosaria Talarico, Marta Mosca
8 [GO] 2023―Oct―17 SARS-CoV-2 and thyroid diseases Małgorzata Staruszkiewicz, Anna Pituch-Noworolska, Szymon Skoczen
9 [GO] 2023―Oct―14 Role of autoantibodies targeting interferon type 1 in COVID-19 severity: A systematic review and meta-analysis Abolfazl Akbari, Alireza Hadizadeh, Mahdi Amiri, Neshat Najaf Najafi, Zahra Shahriari, Tannaz Jamialahmadi, Amirhossein Sahebkar
10 [GO] 2023―Oct―09 Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase Clodoveo Ferri, Vincenzo Raimondo, Dilia Giuggioli, Laura Gragnani, Serena Lorini, Lorenzo Dagna, Silvia Laura Bosello, Rosario Foti, Valeria Riccieri, Serena Guiducci, Giovanna Cuomo, Antonio Tavoni, Rossella De Angelis, Fabio Cacciapaglia, Elisabetta Zanatta, Franco Cozzi, Giuseppe Murdaca, Ilaria Cavazzana, Nicoletta Romeo, Veronica Codullo, Roberta Pellegrini, Giuseppe Varcasia, Maria De Santis, Carlo Selmi, Giuseppina Abignano, Maurizio Caminiti, Massimo L'Andolina, Domenico Olivo, Ennio Lubrano, Amelia Spinella, Federica Lumetti, Giacomo De Luca, Piero Ruscitti, Teresa Urraro, Marcella Visentini, Silvia Bellando-Randone, Elisa Visalli, Davide Testa, Gabriella Sciascia, Francesco Masini, Greta Pellegrino, Francesca Saccon, Eugenia Balestri, Giusy Elia, Silvia Martina Ferrari, Antonio Tonutti, Francesca Dall’Ara, Giuseppa Pagano Mariano, Giorgio Pettiti, Giovanni Zanframundo, Raffaele Brittelli, Vincenzo Aiello, Ylenia Dal Bosco, Roberta Foti, Ilenia Di Cola, Daniela Scorpiniti, Enrico Fusaro, Tommaso Ferrari, Pietro Gigliotti, Corrado Campochiaro, Francesca Francioso, Carlo Iandoli, Virginia Caira, Anna Linda Zignego, Salvatore D'Angelo, Franco Franceschini, Marco Matucci-Cerinic, Roberto Giacomelli, Andrea Doria, Stefano Angelo Santini, Poupak Fallahi, Florenzo Iannone, Alessandro Antonelli
11 [GO] 2023―Apr―06 Glucocorticoids selectively affect the memory T cell response to SARS-Cov2 spike in vaccinated and post-infected patients with systemic lupus erythematosus Yves Renaudineau, Chloé Bost, Florence Abravanel, Jacques Izopet, Antoine Blancher, Nicolas Congy, Emmanuel Treiner, Laurent Sailler
12 [GO] 2023―Jan―14 COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection Cloé Comarmond, Elodie Drumez, Julien Labreuche, Eric Hachulla, Thierry Thomas, René-Marc Flipo, Raphaëlle Seror, Jérôme Avouac, Nathalie Balandraud, Renaud Desbarbieux, Renaud Felten, Mélanie Gilson, Marie-Hélène Guyot, Ambre Hittinger-Roux, Thao Pham, Myriam Renard, Nicolas Roux, Vincent Sobanski, Anne Tournadre, Christophe Richez, Patrice Cacoub
13 [GO] 2022―Nov―25 Transient expression of antinuclear RNP-A antibodies in patients with acute COVID-19 infection Shuxia Zhou, Ravi Kaul, Kara L. Lynch, Alan H.B. Wu, Roger P. Walker
14 [GO] 2022―Sep―13 COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies Laura Gragnani, Marcella Visentini, Serena Lorini, Francesca La Gualana, Stefano Angelo Santini, Fabio Cacciapaglia, Antonio Tavoni, Giovanna Cuomo, Poupak Fallahi, Florenzo Iannone, Alessandro Antonelli, Milvia Casato, Anna Linda Zignego, Clodoveo Ferri
15 [GO] 2022―Apr―13 SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases Regina Larionova, K. Byvaltsev, Оlga Kravtsova, Elena Takha, Sergei Petrov, Gevorg Kazarian, Anna Valeeva, Eduard Shuralev, Malik Mukminov, Yves Renaudineau, Marina Arleevskaya
16 [GO] 2022―Feb―25 A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases Julia Y. Wang, Michael W. Roehrl, Victor B. Roehrl, Michael H. Roehrl
17 [GO] 2022―Jan―04 COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature Laura Camacho-Domínguez, Yhojan Rodríguez, Fernando Polo, Juan Carlos Restrepo Gutierrez, Elizabeth Zapata, Manuel Rojas, Juan-Manuel Anaya
18 [GO] 2021―Aug―31 Celiac disease in the COVID-19 pandemic Gabriel Samasca, Aaron Lerner
19 [GO] 2021―Aug―19 Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab Lisa C. Plymate, Gregory Pepper, Maxwell P. Krist, David M. Koelle
20 [GO] 2021―Mar―23 Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab Sohier Elneil, Jacob P. Lalezari, Nader Z. Pourhassan
21 [GO] 2021―Mar―02 Latent Rheumatic, Thyroid and Phospholipid Autoimmunity in Hospitalized Patients with COVID-19 Juan-Manuel Anaya, Diana M. Monsalve, Manuel Rojas, Yhojan Rodríguez, Norma Montoya-García, Laura Milena Mancera-Navarro, Ana María Villadiego-Santana, Giovanni Rodríguez-Leguizamón, Yeny Acosta-Ampudia, Carolina Ramírez-Santana
22 [GO] 2021―Feb―16 Benefits of early aggressive immunomodulatory therapy (tocilizumab and methylprednisolone) in COVID-19: single center cohort study of 685 patients Buzón-Martín Luis, Montero-Baladía Miguel, Delgado-López Pedro, Iglesias-Posadilla David, Astigarraga Itziar, Galacho-Harriero Ana, Iglesias-Julián Enrique, López-Veloso María, De La Torre-Ferrera Noelia, Barraza-Bengoechea Julio César, Ubeira- Iglesias Marta, San Llorente- Sebastián Rodrigo, Colazo-Burlato María, Lorenzo-Martín Andrés, Minguito de la Iglesia Javier, García-Muñoz Juan Pablo, Hermida-Fernández Gerardo, Navarro-San Francisco Carolina, Boado-Lama Jorge, Fernández-Regueras María, Callejo-Torre Fernando, Ossa-Echeverri Sergio, Fisac-Cuadrado Lourdes, Gero-Escapa María, Megías-Lobón Gregoria, Simón-Rodríguez Adolfo, Fernández-Ratero José Antonio
23 [GO] 2021―Jan―29 Characteristics of COVID-19 infection and antibody formation in a Tertiary Immunology department N.A.D. Guchelaar, J.A.M. van Laar, M.A.W. Hermans, T.B. van der Houwen, S. Atmaca, M.S. van Maaren, Z. Brkic, P.L.A. van Daele, V.A.S.H. Dalm, P.M. van Hagen, S.M. Rombach
24 [GO] 2021―Jan―10 Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: case series of four critically ill patients treated with leronlimab Nicholas Agresti, Jacob P. Lalezari, Phillip P. Amodeo, Kabir Mody, Steven F. Mosher, Harish Seethamraju, Scott A. Kelly, Nader Z. Pourhassan, C. David Sudduth, Christopher Bovinet, Ahmed E. ElSharkawi, Bruce K. Patterson, Reejis Stephen, Jonah B. Sacha, Helen L. Wu, Seth A. Gross, Kush Dhody
25 [GO] 2020―Nov―27 Prevalence of Autoantibody Responses in Acute Coronavirus Disease 2019 (COVID-19) L. Angelica Lerma, Anu Chaudhary, Andrew Bryan, Chihiro Morishima, Mark H. Wener, Susan L. Fink
26 [GO] 2020―Nov―05 Why will it never be known if convalescent plasma is effective for COVID-19 Manuel Rojas, Juan-Manuel Anaya
27 [GO] 2020―Apr―09 Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity James Lyons-Weiler
 [1] 

27 Results       Page 1



[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec